Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shexiang Tongxin Dropping Pill for stable coronary artery disease with normal FFR and coronary microvascular disease
ChiCTR2000032429Phase 4Recruiting
- Sponsor
- Sir Run-Run Shaw Hospital
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Shexiang Tongxin Dropping Pills in Coronary Small Vessel Disease (CMD) and coronary arteriosclerosis (2 arms), sponsored by Sir Run-Run Shaw Hospital. Primary endpoint: Index of Microcirculatory Resistance. Started Apr 2020; status: recruiting.
02
Drugs
Shexiang Tongxin Dropping Pills
03
Conditions
Coronary Small Vessel Disease (CMD)coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR2000032429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032429.